Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 3/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.35 |
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALPG | P10696 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPY2R | P49146 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6832596 | 0.81 | CA2 (0.39) | CA2CA4CA5ATSHRESR1 | |
| SCHEMBL7078417 | 0.77 | CA2 (0.36) | CA2CA4CA5ATSHRESR1 | |
| SCHEMBL28459717 | 0.73 | CA2 (0.43) | CA2CA4CA5ATSHRESR1 | |
| SCHEMBL361668 | 0.73 | CA2 (0.43) | CA2CA4CA5ATSHRESR1 | |
| SCHEMBL2932036 | 0.72 | CA2 (0.47) | CA2CA4CA5ATSHRESR1 | |
| Water SCHEMBL7532602 | 0.71 | CA2 (0.41) | CA2CA4CA5ATSHRESR1 | |
| Hydrochloric Acid SCHEMBL2582115 | 0.71 | CA2 (0.41) | CA2CA4CA5ATSHRESR1 | |
| Hydrochloric Acid SCHEMBL996153 | 0.71 | CA2 (0.41) | CA2CA4CA5ATSHRESR1 | |
| Fluoride SCHEMBL11191593 | 0.71 | CA2 (0.41) | CA2CA4CA5ATSHRESR1 | |
| SCHEMBL6316218 | 0.71 | CA2 (0.41) | CA2CA4CA5ATSHRESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050282982-A1 | Amido complexes of vanadium for olefin polymerization | LANXESS DEUTSCHLAND GMBH (DE) | 2005-12-22 | — | — | US | disclosed |
| EP-1607397-A1 | Vanadium-amido complexes for olefin polymerization | Lanxess Deutschland GmbH (DE) | 2005-12-21 | — | — | EP | disclosed |
| EP-1284270-B1 | Vanadium-Imido-Phosphoraniminato complexes for olefin polymerisation | BAYER AG (DE) | 2005-06-29 | — | — | EP | disclosed |
| US-6846769-B2 | Vanadium-imido-phosphoraneiminato complexes for the polymerization of olefins | BAYER AKTIENGESELLSCHAFT (DE) | 2005-01-25 | — | — | US | disclosed |
| US-20030114675-A1 | Vanadium-imido-phosphoraneiminato complexes for the polymerization of olefins | LANXESS DEUTSCHLAND GMBH (DE) | 2003-06-19 | — | — | US | disclosed |
| EP-1284270-A1 | Vanadium-Imido-Phosphoraniminato complexes for olefin polymerisation | BAYER AG (DE) | 2003-02-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114675-A1 | Vanadium-imido-phosphoraneiminato complexes for the polymerization of olefins | MVD, PPIP5K2, PI4KA | CA2 4297/4885CA4 3424/4885CA5A 4599/4885 |
| US-20050282982-A1 | Amido complexes of vanadium for olefin polymerization | NOX4, NOXO1, COG4 | CA2 4160/4885CA4 1518/4885CA5A 2742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.